ERW awards Elizabeth Hill drill contract
Errawarra is gearing up for diamond drilling at its Elizabeth Hill silver project after locking in drilling contractor West Core Drilling.
Stockhead
Long Shortz: Neurizon Therapeutics
Tylah Tully speaks with Neurizon MD Michael Thurn after the final patient completes treatment in the NUZ-001 OLE study.
Hungarian hospital debuts Imricor mapping system
A procedure has now been performed using Imricor’s 3D mapping system in a prominent Hungarian hospital.
The strategy is clear for this x-ray imaging house
As part of a “strategy re-set” x-ray imaging house Micro-X has focused on medical applications, rather than security and defence uses.
More Stories
ATC advances silicon in batteries tech
Altech’s latest Silumina Anode technological breakthrough has delivered a 50% capacity improvement in battery applications.
BTR US$11.5m working capital facility to advance gold production
Brightstar Resources has executed a working capital facility with Ocean Partners Australia to boost CY25 production and accelerate exploration.
NTI164 shows strong safety in tox tests
Neurotech clears key safety hurdle for NTI164, paving the way for longer studies and global filings.
EBR applies for cardiac device outpatient reimbursement
Having already received a recommendation for inpatients from the CMS, EBR is now applying for reimbursement for its WISE CRT System for outpatients under the same criteria.
KNG starts Leliyn scoping study
Kingsland’s scoping study for Leliyn will be underpinned by the initial indicated resource of 1Mt contained graphite.
WCN looks to maiden copper resource at Rae project
White Cliff Minerals has reported up to 4.46% copper from RC drilling at its Rae project in Canada, with results to inform a maiden resource estimate.
Uranium rebound? Five reasons it could happen
Uranium prices are showing renewed signs of life. Which juniors have the most leverage if the comeback goes nuclear?
Trump powers copper dream
Copper explorers in the United States are toasting the best regulatory conditions they’ve seen in years in the early days of Trump 2.0.
Neurizon trial reveals heightened ALS survival rate
Neurizon’s NUZ-001 treatment has demonstrated increased survival in patients with ALS, reducing risk of death by 78.5pc.
WTF: Arovella Therapeutics
Arovella Therapeutic’s CEO reveals what iNKT cell therapies are, how they work and why they are promising for cancer treatment.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/6